ELAVL1 and cancer: RBM3 can bind to and alter the translation of mRNA, as shown for COX-2, IL-8, and vascular endothelial growth factor (VEGF) in macrophages or cancer cells [65, 133], presumably in a cell type-specific manner [36] and involving the interaction with HuR [133].